Skip to main content

Month: August 2024

Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2025

Definitive agreement with Aditxt, if approved by Appili shareholders, provides significant premium to shareholders and resources to advance key programs ATI-1701 funding commitments from U.S. Air Force Academy and interactions with the U.S. Food and Drug Administration, confirming the development pathway through IND submission U.S. Food and Drug Administration meeting request submitted to discuss ATI-1801 registration strategy HALIFAX, Nova Scotia, Aug. 13, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and operational results for the first quarter of its fiscal year 2025, which ended on June 30, 2024. All figures are stated in Canadian...

Continue reading

Etrion Releases Second Quarter 2024 Results

GENEVA, Aug. 13, 2024 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”, and, together with its subsidiaries, the “Group”) released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and six months ended June 30, 2024. Q2-24 HIGHLIGHTSEtrion closed the second quarter of 2024 with an unrestricted cash balance of US$5.9 million and a positive working capital of US$5.6 million.Management Comments: Marco A. Northland, the Company’s Chief Executive Officer, commented, “The Company going forward will maintain very limited resources and proceed with a windup of the Company as previously disclosed.” FINANCIAL SUMMARY  Three months ended Six months endedUS$ thousands (unless otherwise stated) Q2-24 Q2-23 Q2-24 Q2-23         Financial...

Continue reading

K92 Mining Announces 2024 Q2 Financial Results – Strong Financial Position and Stage 3 and 4 Expansions Fully Financed

VANCOUVER, British Columbia, Aug. 13, 2024 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce financial results for the three and six months ended June 30, 2024. ProductionQuarterly production of 24,347 ounces gold equivalent (“AuEq”) or 21,661 oz gold, 1,246,639 lbs copper and 26,754 oz silver (1). Production for the quarter was impacted by the temporary suspension of operations as previously announced. Cash costs of US$919/oz gold and all-in sustaining costs (“AISC”) of US$1,510/oz gold (2). Strong metallurgical recoveries in Q2 of 93.7% gold and 95.3% copper, representing the highest gold recoveries since Q4 2019 and record quarterly recoveries to date for copper. Quarterly ore processed of 95,582 tonnes and total ore mined of 99,209 tonnes, with long hole open stoping...

Continue reading

Lowell Farms Inc. Announces Unaudited Second Quarter 2024 Financial and Operational Results

SALINAS, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis company with advanced distribution and production capabilities including extraction, manufacturing, sales and brand management, announces unaudited revenue and operating results for the second quarter of 2024 (ended June 30, 2024). All figures stated are in US Dollars. Second Quarter Financial Highlights:Net revenue generated for the quarter ended June 30, 2024 decreased 50% to $3.5 million, as compared to $7.0 million for the second quarter last year. Net revenue decreased 27% from $4.9 million in the first quarter of 2024.CPG revenue decreased 11% for the quarter ended June 30, 2024 compared to the quarter ended June 30, 2023 and decreased 15% compared to the first quarter of 2024. Bulk Product...

Continue reading

Clairvest Reports Fiscal 2025 First Quarter Results

TORONTO, Aug. 13, 2024 (GLOBE NEWSWIRE) — Clairvest Group Inc. (TSX: CVG) today reported results for the fiscal 2025 first quarter ended June 30, 2024 and events which occurred subsequent to quarter end. (All figures are in Canadian dollars unless otherwise stated) HighlightsJune 30, 2024 book value was $1,186.2 million or $81.02 per share compared with $1,176.3 million or $80.16 per share as at March 31, 2024 Net income for the quarter ended June 30, 2024 was $23.9 million or $1.63 per share Clairvest and Clairvest Equity Partners VI (“CEP VI”) made two platform investments during the quarter to complete the CEP VI Fund investment program and Clairvest commenced the CEP VII investment program Clairvest and Clairvest Equity Partners V (“CEP V”) completed the sale of Durante Rentals Subsequent to quarter end, Clairvest, CEP V...

Continue reading

AirBoss Reports 2nd Quarter 2024 Results

NEWMARKET, Ontario, Aug. 13, 2024 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (OTCQX: ABSSF) (the “Company” or “AirBoss”) today announced its second quarter 2024 results. The Company will host a conference call and webcast to discuss the results on August 14th at 9:00 a.m. (ET), the details of which are outlined below. All dollar amounts are shown in thousands of United States dollars (“US $” or “$”), except per share amounts, unless otherwise noted. Recent HighlightsCommenced shipments in the third quarter of 2024 under AirBoss Manufactured Products’ defense business’ recently-announced contract valued at up to $45 million to provide its Bandolier multipurpose energetic system to a NATO partner nation; Declared a quarterly dividend of C$0.035 per common share; Retained TD Securities Inc....

Continue reading

Westport Reports Second Quarter 2024 Financial Results and Revises Segment Reporting

VANCOUVER, British Columbia, Aug. 13, 2024 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport“) (TSX:WPRT / Nasdaq:WPRT), a leading supplier of advanced alternative fuel systems and components for the global transportation industry, reported financial results for the second quarter ended June 30, 2024, and provided an update on operations. All figures are in U.S. dollars unless otherwise stated. “In the second quarter of 2024, we remained focused on implementing the Company’s three strategic pillars: harnessing the potential of our HPDI joint venture, enhancing operational excellence, and continuous innovation to shape the world’s hydrogen-powered future. We celebrated several accomplishments consistent with our priorities and continue to recognize we have more work to do. The closing of our HPDI joint venture with...

Continue reading

Beam Global Announces Record Second Quarter 2024 Operating Results

Conference Call Tuesday August 13, 2024 at 4:30 p.m. ET SAN DIEGO, Aug. 13, 2024 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM), (the “Company”), a provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy security, today announced its second quarter results for the period ended Q2 2024. Q2 2024 Financial Highlights:Increased revenue 2% to $14.8 million over Q1 2024 Record gross margin of 16%, an increase over Q1 2024 of 6 percentage points 31% of revenue derived from commercial customers Backlog of $11 million; record pipeline of over $183 million Net cash used of $0.1 million in operating activities for the six months ended Q2 2024 Debt free and $100 million line of credit available and unusedQ2 2024 and Recent Operational Highlights:Q2 purchase orders up 129% year-over-year...

Continue reading

Inspirato Announces Second Quarter Results and Closing of $10 Million Investment Agreement with One Planet Group LLC

DENVER, Aug. 13, 2024 (GLOBE NEWSWIRE) — Inspirato Incorporated (“Inspirato” or the “Company”) (NASDAQ: ISPO), the innovative luxury travel club, today announced its 2024 second quarter financial and operating results, the closing of its previously announced $10 million Investment Agreement with One Planet Group LLC (“One Planet Group”) and is in the process of implementing initiatives expected to reduce costs by approximately $25 million on an annualized basis. Except as otherwise stated, all financial results discussed below are presented in accordance with generally accepted accounting principles in the United States of America, or GAAP. As supplemental information, we have provided certain additional non-GAAP financial measures in this press release’s supplemental tables, and such supplemental tables include a reconciliation...

Continue reading

Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

• AMPLIFY-7P Phase 1 preliminary disease-free (“DFS”) survival demonstrates strong correlation between T cell response and reduced risk of progression or death• AMPLIFY-7P Phase 1 data presented at ASCO demonstrated 100% of patients develop mKRAS-specific T-cell response with ~66% of responses including both CD4+ and CD8+ T cells• Long term follow up of the AMPLIFY-201 Phase 1 study will be terminated, and long term follow up of the AMPLIFY-7P Phase 1 study will be minimized to collect only overall survival to preserve resources with updated data to be shared at upcoming medical meetings• AMPLIFY-7P Phase 2 randomized clinical trial anticipated to complete 135-patient enrollment in the fourth quarter of 2024• $43 million raised in 2024 funds Elicio into the second quarter of 2025 BOSTON, Aug. 13, 2024 (GLOBE NEWSWIRE) — Elicio...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.